The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis
Clinical trial NCT03040427 · TERMINATED
Trial details
- NCT number
- NCT03040427
- Sponsor
- The Cleveland Clinic
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2019-08-21
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.